Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,742 | 1,793 | 2,835 | 1,572 | 1,745 |
| Marketable Securities | 3,722 | 1,529 | 13,051 | 1,208 | 2,949 |
| Receivables | 1,887 | 2,727 | 1,717 | 334 | 1,027 |
| Inventories | 7,002 | 8,428 | 3,712 | 510 | 345 |
| Other current assets | 1,032 | 600 | 413 | 1,079 | 110 |
| TOTAL | $16,385 | $15,077 | $21,728 | $4,704 | $6,175 |
| Non-Current Assets | |||||
| PPE Net | 5,107 | 5,383 | 5,059 | 3,160 | 3,840 |
| Investments And Advances | 0 | 2,620 | 1,558 | 1,418 | 0 |
| Other Non-Current Assets | 2,016 | 1,298 | 2,753 | 313 | 1,548 |
| TOTAL | $7,123 | $9,301 | $9,370 | $4,891 | $5,388 |
| Total Assets | $23,508 | $24,378 | $31,115 | $9,595 | $11,563 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,200 | 298 | 280 | 0 | 0 |
| Accounts payable and accrued liabilities | 6,155 | 1,829 | 590 | 441 | 351 |
| Accrued Expenses | 2,388 | 2,077 | 532 | 499 | 414 |
| Other current liabilities | 0 | 6,317 | 3,000 | 1,500 | 1,500 |
| TOTAL | $10,743 | $10,521 | $7,300 | $2,443 | $2,264 |
| Non-Current Liabilities | |||||
| Long Term Debt | 979 | 3,355 | 3,672 | 4,000 | 3,000 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 82 | 0 |
| TOTAL | $979 | $3,355 | $3,672 | $4,082 | $3,000 |
| Total Liabilities | $11,722 | $13,876 | $10,971 | $6,443 | $5,264 |
| Shareholders' Equity | |||||
| Common Shares | 160 | 137 | 130 | 100 | 97 |
| Retained earnings | -52,844 | -43,012 | -33,082 | -27,414 | -23,118 |
| Other shareholders' equity | 4,173 | 2,300 | 2,301 | 1 | 32 |
| TOTAL | $11,786 | $10,501 | $20,143 | $3,071 | $6,299 |
| Total Liabilities And Equity | $23,508 | $24,377 | $31,114 | $9,514 | $11,563 |